Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-01-05

Clinical Trial Update: A Trial to Assess the Efficacy and Safety of Morinidazole in Women With Pelvic Inflammatory Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the efficacy and safety of Morinidazole in women with pelvic inflammatory disease is underway, with status currently unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Morinidazole (morinidazole)

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: Pelvic Inflammatory Disease | Phase 4 | Status: UNKNOWN